MedTrace Logo

A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia

NCT05820035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2025-05-28

No results posted yet for this study

Summary

The purpose of this study was to explore the safety and efficacy of pulsed field ablation（PFA) in the treatment of paroxysmal pupraventricular pachycardia（PSVT）with a contact force(CF)-sensing PFA Catheter

Conditions

  • Paroxysmal Supraventricular Tachycardia
  • Atrioventricular Nodal Reentrant Tachycardia
  • Atrioventricular Reciprocating Tachycardia

Interventions

DEVICE

Pulsed Field Ablation Device and CF-Sensing Pulsed Field Ablation Catheter

All subjects will be ablated using the pulsed field ablation device and CF-sensing pulsed field ablation catheter in the management of their paroxysmal supraventricular tachycardia

Sponsors & Collaborators

  • Shanghai MicroPort EP MedTech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-09
Primary Completion
2024-02-23
Completion
2024-12-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05820035 on ClinicalTrials.gov